There’s no question that the life science fields – such as pharmaceuticals and biotechnology – are intensely competitive. New drugs, therapies and devices are continually being developed and enter the market daily. Companies need to target new products to physicians who are diagnosing patients with relevant conditions.
Not to mention this is all happening in a rapidly changing landscape in which fewer doctors practice independently, and a growing number work for groups and hospitals.
To ensure their products gain market traction, life sciences companies would benefit from improving their management and leveraging of claims data. If done right, this can help them home in on the best targets. Our new playbook examines the changing landscape and provides recommendations on how to best navigate the evolving industry. We'll also cover: